Related Experiment Video
Updated: Sep 8, 2026

Assaying the Kinase Activity of LRRK2 in vitro
Published on: January 18, 2012
Cryo-electron tomography reveals the microtubule-bound form of inactive LRRK2
Siyu Chen1,2,3, Tamar Basiashvili1,2, Joshua Hutchings1
1Department of Molecular Biology, University of California, San Diego, La Jolla, CA 92093, USA.
Abstract:
Parkinson's Disease (PD) is the second most common neurodegenerative disorder. Mutations in leucine-rich repeat kinase 2 (LRRK2), a multi-domain protein containing both a kinase and a GTPase, are a leading cause of the familial form of PD. Pathogenic LRRK2 mutations increase LRRK2 kinase activity. While the bulk of LRRK2 is found in the cytosol, the protein associates with membranes where its Rab GTPase substrates are found, and under certain conditions, with microtubules. Integrative structural studies using single-particle cryo-electron microscopy (cryo-EM) and in situ cryo-electron tomography (cryo-ET) have revealed the architecture of microtubule-associated LRRK2 filaments, and that formation of these filaments requires LRRK2's kinase to be in the active-like conformation. However, whether LRRK2 can interact with and form filaments on microtubules in its autoinhibited state, where the kinase domain is in the inactive conformation and the N-terminal LRR domain covers the kinase active site, was not known. Using cryo-ET, we show that full-length LRRK2 can oligomerize on microtubules in its autoinhibited state. Both WT-LRRK2 and PD-linked LRRK2 mutants formed filaments on microtubules. While these filaments are stabilized by the same interfaces seen in the active-LRRK2 filaments, we observed a new interface involving the N-terminal repeats that were disordered in the active-LRRK2 filaments. The helical parameters of the autoinhibited-LRRK2 filaments are different from those reported for the active-LRRK2 filaments. Finally, the autoinhibited-LRRK2 filaments are shorter and less regular, suggesting they are less stable.
Insights
Leucine-rich repeat kinase 2 (LRRK2) forms filaments on microtubules even in its inactive state. This finding is crucial for understanding Parkinson's Disease (PD) pathogenesis and LRRK2's complex behavior.
Area of Science:
- Neuroscience
- Structural Biology
- Molecular Biology
Background:
- Parkinson's Disease (PD) is a common neurodegenerative disorder.
- Mutations in leucine-rich repeat kinase 2 (LRRK2) are a primary cause of familial PD.
- LRRK2's kinase activity is elevated in pathogenic mutations and it associates with cellular structures like microtubules.
Purpose of the Study:
- To investigate if leucine-rich repeat kinase 2 (LRRK2) can form filaments on microtubules in its autoinhibited (inactive) state.
- To characterize the structural features and stability of autoinhibited LRRK2 filaments on microtubules.
Main Methods:
- Utilized *in situ* cryo-electron tomography (cryo-ET) to visualize LRRK2 structures.
- Examined full-length wild-type (WT) and Parkinson's Disease-linked mutant LRRK2.
- Analyzed LRRK2 oligomerization and filament formation on microtubules.
Main Results:
- Full-length LRRK2, including PD-linked mutants, forms filaments on microtubules in its autoinhibited state.
- These filaments exhibit distinct structural interfaces, including a novel interaction involving N-terminal repeats.
- Autoinhibited LRRK2 filaments display different helical parameters and are less stable than active LRRK2 filaments.
Conclusions:
- LRRK2 can oligomerize and form filaments on microtubules irrespective of its kinase activity state.
- The autoinhibited state of LRRK2 reveals new structural insights, particularly involving its N-terminal domains.
- Understanding LRRK2 filament formation in different conformational states is vital for Parkinson's Disease research.

